This inventor holds 2 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignee: Elucida Oncology, Inc.. Active years: 2023-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2024
Title: Innovations of Inventor Kai Ma
Introduction
Kai Ma is an accomplished inventor based in Montgomery, NJ (US). He has made significant contributions to the field of oncology through his innovative work in nanoparticle drug conjugates. With a total of 2 patents to his name, his research focuses on targeted cancer therapies.
Latest Patents
Kai Ma's latest patents include "Folate receptor targeted nanoparticle drug conjugates and uses thereof." This patent discloses nanoparticle drug conjugates (NDC) that comprise ultrasmall nanoparticles, folate receptor (FR) targeting ligands, and linker-drug conjugates. The methods outlined in this patent aim to treat cancer effectively.
Career Highlights
Kai Ma is currently associated with Elucida Oncology, Inc., where he continues to advance his research in cancer treatment. His work is pivotal in developing new therapeutic strategies that leverage the unique properties of nanoparticles.
Collaborations
Some of his notable coworkers include Aranapakam Mudumbai Venkatesan and Feng Chen. Their collaborative efforts contribute to the innovative research environment at Elucida Oncology, Inc.
Conclusion
Kai Ma's contributions to the field of oncology through his patents and work at Elucida Oncology, Inc. highlight his commitment to advancing cancer treatment. His innovative approaches are paving the way for new therapeutic options in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile